Regulatory Affairs
🇺🇸 FDA Page 2FDA news and analysis for pharmaceutical BD, investment, and market access · 10 articles on this page
Navigate global pharma regulatory affairs. Get expert insights on FDA, EMA, and global compliance for drug approvals, market access, and R&D strategy.
Showing 13–22 of 22 articles
FDA Accelerates Mental Health Treatment Access Following Presidential Executive Order on Serious Mental Illness
Tivic Health Rebrands as Valion Bio, Advances Entolimod for Acute Radiation Syndrome with FDA Fast Track Status
AbbVie Receives FDA Complete Response Letter for TrenibotulinumtoxinE (TrenibotE) Manufacturing Issues
Pediatric Clinical Trials: FDA's Updated Requirements and Incentives
Aquestive Therapeutics Faces FDA Deficiencies for Anaphylm Drug Application, Class Action Lawsuit Filed
Outlook Therapeutics Completes FDA Dispute Resolution Meeting for LYTENAVA Bevacizumab Biosimilar
Clinical Trial Protocol Amendments: FDA Insights on Timeline & Cost Impact
Debiopharm's Lunresertib Receives FDA Fast Track Designation for Platinum-Resistant Ovarian Cancer Treatment
Diversity in Clinical Trials: FDA's New Guidance and Early Impact
African Medicines Agency Impact: Multi-Regional Clinical Trials First Year Review